Your Comments On...

This Pill Not To Be Taken With Competition

Getting health-care costs under control is a daunting and multifaceted challenge. But one simple approach could save consumers billions of dollars annually: stopping pharmaceutical companies from colluding with competitors to keep lower-cost generic alternatives to prescription drugs off the market.
 - 

By Jon Leibowitz

 
Comments
© 2008 The Washington Post Company